Feeding Effect of Terminalia Arjuna and Guggul on the Biophysical Symptoms of Dyslipidemic Patients

Publication Date : 30/03/2016


Author(s) :

Jain Bharti , Pathak Sakshi , Yadav Shubha.


Volume/Issue :
Volume 2
,
Issue 3
(03 - 2016)



Abstract :

Cardio Vascular Disease (CVD) is a chronic, potentially debilitating disease and its prevalence is increasing in all populations in worldwide. Dyslipidemia and Hypertension are closely linked to the pathophysiology of the CVD and are key independent modifiable risk factors for CVD. The bark of the Arjuna is rich in¬ polyphenols and bark of Guggul is rich in guggulsteroneboth are useful as an anti-ischemic and cardio protective agents in Hypertension and Dyslipidemia. The present study was undertaken to assess the impact of Arjuna and Guggul on Blood Pressure of the subjects with Dyslipidemia patient. Purposive random sampling method was chosen to select already diagnosed dyslipidemic male. Out of the total 40 subjects 10 subjects comprised the Control group and 30 subjects comprised Experimental group. In the Experimental group A (10 subjects) were given capsules of Arjuna (1 gm. powder), group B (10 subjects) were given capsules of Guggul (1 gm. powder) and group C (10 subjects) were given capsules of Mixed herb (500 mg Arjuna powder and 500 mg Guggul powder). BMI, Diastolic and Systolic blood pressure were assessed at baseline and after intervention. A self-administrated pre-tested questionnaire was developed to collect general and disease specific information from subjects. In the experimental group the mean BMI, Diastolic and systolic blood pressure decreased significantly after intervention. A statistical significant difference in mean BMI, Diastolic and systolic blood pressure was observed between Experimental and Control group. Supplementation with capsules of Arjuna, Guggul and Mixed herb (both Arjuna and Guggul) brought about a decrease in BMI and blood pressure levels. Thus Arjuna and Guggul can be explored for its beneficial effect in management of Obesity, Hypertension, Dyslipidemia and CVD.


No. of Downloads :

2